Absenteeism and indirect costs during the year following the diagnosis of an operable breast cancer: A prospective multicentric cohort study

Diseases consequence on individual work as much consequences of being absent from are matters interest for decision makers. We analyzed lengths absenteeism and related indirect costs patients with a paid activity in the year following diagnosis early stage breast cancer, prospective OPTISOINS01 cohort. Both human capital friction approach were considered valuation lost working days (LWD). For analysis, period was estimated recent French data. The statistical analysis included simple multiple linear regression to search determinants costs. 93 % had at least one sick leave, average 2 186 leave. 24 part-time resumption after their leave periods, during 114 (i.e. 41 LWD). Estimated 22,722.00 € 7,724.00 per patient, respectively cost approach. In model, factors associated were: invasive nature tumor (p = .043), mastectomy .038), surgery revision .002), chemotherapy .027), manager .025) or craftsman .005). Breast cancer lead important diagnosis, but almost all able return work. Using led an gap results, highlighting importance considering both such studies.